ERIC THOMAS SCHMIDT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ERIC THOMAS SCHMIDT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ERIC THOMAS SCHMIDT. ERIC THOMAS SCHMIDT is a Director in RELMADA THERAPEUTICS, INC. ($RLMD) and a Director in Revolution Medicines, Inc. ($RVMD) and a Chief Financial Officer in Allogene Therapeutics, Inc. ($ALLO).
Address: 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO 94080 CA
Companies in which ERIC THOMAS SCHMIDT is an Insider
Allogene Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ERIC THOMAS SCHMIDT: Chief Financial Officer
Holdings: 96,097 shares
Latest Transaction: Mar 30 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RELMADA THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ERIC THOMAS SCHMIDT: Director
Holdings: 87,500 shares
Current Value: $95,375
Latest Transaction: Jan 11 2021
$RLMD Market Capitalization: $12.16M
$RLMD Previous Close: $1.09
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Revolution Medicines, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of ERIC THOMAS SCHMIDT: Director
Holdings: 7,234 shares
Latest Transaction: Jun 19 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ERIC THOMAS SCHMIDT
Sentiment: All, ALLO, RLMD, RVMD
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 30 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Option Exercise | A | 33.78 | 92,365 | 3,120,090 | 92,365 | |
| Mar 30 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Grant | A | 0.00 | 24,866 | 0 | 96,097 | 71.2 K to 96.1 K (+34.91 %) |
| Jan 19 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 33.29 | 400 | 13,314 | 1,152,595 | 1.2 M to 1.2 M (-0.03 %) |
| Jan 19 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 32.40 | 11,053 | 358,151 | 1,152,995 | 1.2 M to 1.2 M (-0.95 %) |
| Jan 19 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 31.69 | 3,547 | 112,393 | 1,164,048 | 1.2 M to 1.2 M (-0.30 %) |
| Jan 19 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 31.10 | 5,149 | 160,129 | 1,167,595 | 1.2 M to 1.2 M (-0.44 %) |
| Jan 19 2021 | ALLO | Allogene Therapeut ... | SCHMIDT ERIC THOMAS | Chief Financial Off ... | Sell | S | 30.60 | 9,851 | 301,481 | 1,172,744 | 1.2 M to 1.2 M (-0.83 %) |